Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0091
+0.0002 (2.25%)
Apr 28, 2026, 9:30 AM EST
Emmaus Life Sciences Employees
As of December 31, 2025, Emmaus Life Sciences had 33 total employees, including 32 full-time and 1 part-time employees. The number of employees decreased by 2 or -5.71% compared to the previous year.
Employees
33
Change (1Y)
-2
Growth (1Y)
-5.71%
Revenue / Employee
$377,364
Profits / Employee
-$227,030
Market Cap
638.71K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Eloxx Pharmaceuticals | 10 |
| Hepion Pharmaceuticals | 2 |
| Bio-Path Holdings | 1 |
| Altamira Therapeutics | 11 |
| CNBX Pharmaceuticals | 1 |
Emmaus Life Sciences News
- 4 weeks ago - Emmaus Life Sciences Reports Annual Financial Results - Business Wire
- 4 months ago - Emmaus Life Sciences Announces Strategic Transaction - Business Wire
- 5 months ago - Emmaus Life Sciences Reports Quarterly Financial Results - PRNewsWire
- 10 months ago - Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire
- 1 year ago - Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer - PRNewsWire
- 1 year ago - Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports 2023 Financial Results - PRNewsWire